Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8281522 | 1.00 | CTSD (0.57) | CTSDBACE1 | |
| SCHEMBL5669380 | 0.90 | BACE1 (0.66) | CTSDBACE1 | |
| SCHEMBL8283510 | 0.90 | BACE1 (0.66) | CTSDBACE1 | |
| SCHEMBL5735085 | 0.87 | BACE1 (0.55) | CTSDBACE1 | |
| SCHEMBL8282528 | 0.87 | BACE1 (0.65) | CTSDBACE1 | |
| SCHEMBL5669461 | 0.87 | BACE1 (0.65) | CTSDBACE1 | |
| SCHEMBL5670393 | 0.84 | CTSD (0.71) | CTSDBACE1 | |
| SCHEMBL8283284 | 0.84 | CTSD (0.71) | CTSDBACE1 | |
| SCHEMBL13804626 | 0.82 | BACE1 (0.69) | CTSDBACE1 | |
| SCHEMBL13526072 | 0.82 | BACE1 (0.69) | CTSDBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060014790-A1 | Methods of treatment of amyloidosis using spirocyclohexane aspartyl-protease inhibitors | ELAN PHARMACEUTICALS, INC. | 2006-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060014790-A1 | Methods of treatment of amyloidosis using spirocyclohexane aspartyl-protease inhibitors | ASPH, DNPEP, ACE | CTSD 154/4885BACE1 15/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.